Research graph
References from Decoupling local renin-angiotensin system inhibition from systemic effects: A neutrophil-mimetic, ROS-responsive nanocarrier for precision therapy of myocardial ischemia/reperfusion injury. Local targets link to admitted publications; unresolved targets remain external evidence.
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016
10.1016/s0140-6736(17)32152-9 · 2017 · External reference
Myocardial ischaemia-reperfusion injury and cardioprotection in perspective
10.1038/s41569-020-0403-y · 2020 · External reference
Reperfusion therapy for STEMI: Is there still a role for thrombolysis in the era of primary percutaneous coronary intervention
10.1016/s0140-6736(13)61454-3 · 2013 · External reference
Global epidemiology of heart failure
10.1038/s41569-024-01046-6 · 2024 · External reference
Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats
10.1006/jmcc.1993.1149 · 1993 · External reference
Impact of acute myocardial ischemia reperfusion on the tissue and blood-borne renin-angiotensin system
10.1007/s00395-010-0093-4 · 2010 · External reference
The intracellular renin-angiotensin system in the heart
10.1007/s11906-009-0020-y · 2009 · External reference
Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction
10.1016/j.yjmcc.2009.08.002 · 2010 · External reference
Early initiation of ARBs without blood pressure risk via neutrophil membrane-fused pH-sensitive liposomes to reduce cardiomyocyte apoptosis after acute myocardial infarction
10.1007/s12274-023-5846-0 · 2023 · External reference
Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction
10.1111/bph.13755 · 2017 · External reference
Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology
10.1152/physrev.00038.2017 · 2018 · External reference
Angiotensin II blockade: A strategy to slow ageing by protecting mitochondria
10.1093/cvr/cvq285 · 2011 · External reference
Local angiotensin II aggravates cardiac remodeling in hypertension
10.1152/ajpheart.00538.2010 · 2010 · External reference
Cardiac angiotensin II: Does it have a function
10.1152/ajpheart.00881.2010 · 2010 · External reference
Cardiac remodelling and RAS inhibition
10.1177/1753944716642677 · 2016 · External reference
Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: Effect of early therapy with an angiotensin II type 1 receptor blocker
10.1161/circulationaha.110.948190 · 2010 · External reference
2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines
10.1161/cir.0000000000001346 · 2025 · External reference
2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)
10.1093/eurheartj/ehad191 · 2023 · External reference
Genetically engineered macrophages co-loaded with CD47 inhibitors synergistically reconstruct efferocytosis and improve cardiac remodeling post myocardial ischemia reperfusion injury
10.1002/adhm.202303267 · 2024 · External reference
Biomimetic and NOS‐responsive nanomotor deeply delivery a combination of MSC‐EV and mitochondrial ROS scavenger and promote heart repair and regeneration
10.1002/advs.202301440 · 2023 · External reference
ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury
10.7150/thno.40395 · 2020 · External reference
Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity
10.1002/adma.201900795 · 2019 · External reference
Biomimetic nano-degrader based CD47-SIRPα immune checkpoint inhibition promotes macrophage efferocytosis for cardiac repair
10.1002/advs.202306388 · 2024 · External reference
Platelet-like fusogenic liposome-mediated targeting delivery of miR-21 improves myocardial remodeling by reprogramming macrophages post myocardial ischemia-reperfusion injury
10.1002/advs.202100787 · 2021 · External reference
Monocyte mimics improve mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI/RI model
10.1016/j.biomaterials.2020.120168 · 2020 · External reference
Synergistic enhancement of efferocytosis and cholesterol efflux via macrophage biomimetic nanoparticle to attenuate atherosclerosis progression
10.1016/j.bioactmat.2025.09.022 · 2026 · External reference
Cell membrane coating nanotechnology
10.1002/adma.201706759 · 2018 · External reference
Multifunctional cell membranes-based nano-carriers for targeted therapies: A review of recent trends and future perspective
10.1080/10717544.2023.2288797 · 2023 · External reference
Targeting drugs to tumours using cell membrane-coated nanoparticles
10.1038/s41571-022-00699-x · 2023 · External reference
Moving forwards by blocking back-flow: The Yin and Yang of MI therapy
10.1161/circresaha.115.306569 · 2016 · External reference
Mitochondrial ROS in myocardial ischemia reperfusion and remodeling
10.1016/j.bbadis.2020.165768 · 2020 · External reference
Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities
10.4330/wjc.v10.i9.74 · 2018 · External reference
Comparative efficiency and impact on the activity of blood neutrophils isolated by Percoll, Ficoll and spontaneous sedimentation methods
10.3109/08820139.2015.1085393 · 2016 · External reference
Erythroliposomes: Integrated hybrid nanovesicles composed of erythrocyte membranes and artificial lipid membranes for pore-forming toxin clearance
10.1021/acsnano.8b08964 · 2019 · External reference
A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart
10.1161/circresaha.116.309202 · 2016 · External reference
LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice
10.1002/ejhf.474 · 2016 · External reference
Sacubitril/valsartan averts adverse post-infarction ventricular remodelling and preserves systolic function in rabbits
10.1016/j.jacc.2018.07.102 · 2018 · External reference
